Donate For Public and Patients Store Search

F091 - What's That? Syndrome Update

Sunday, March 3; 1:00 PM - 3:00 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Recognize genetic syndromes associated with disordered pigmentation.
  • Diagnose genetic skin disorders that increase internal cancer risk.
  • Distinguish genetics disorders of connective tissue.

Description

Using clinical examples, this session will focus on recognizable genetic skin syndromes (genodermatoses) that are associated with underlying features and disease. The session is directed to clinicians and individuals interested in learning clinical phenotypes and current concepts about genetic disease affecting the skin. Connective tissue diseases (e.g. Ehlers-danlos syndrome), single gene cancer predisposition syndromes (e.g. Lynch syndrome, Birt-Hogg-Dube) and pigmentation disorders (e.g. cutaneous mosaicism) will be emphasized.

Disclosures

  • Dyer, Jonathan A., MD: Allergan, Inc – I(NC); Scioderm – I(NC);
  • Hand, Jennifer L., MD: UpToDate, Inc – C(IP);
  • Schaffer, Julie V., MD: no financial relationships exist with commercial interests.
Schedule
Sunday, March 3
1:00 PM
Dr. Schaffer / Syndromes Associated with Pigment Alterations
1:40 PM
Dr. Hand / Syndromes that Increase Cancer Risk
2:20 PM
Dr. Dyer / Syndromes with Disordered Connective Tissue
Event Details
  • Date
    Sunday, March 3
  • Time
    1:00 PM - 3:00 PM
  • Location
    Room 101
  • CME Credits
    2.00
  • Type
Directors/Co-Directors
Speakers